Convalescent plasma or hyperimmune immunoglobulin for people with COVID‐19: a living systematic review

Second living update (19 studies; n= 36,081 received convalescent plasma) found uncertain evidence on whether convalescent plasma is beneficial for people admitted to hospital with COVID‐19 and in the absence of control group, uncertainty about relative safety.

Source:

Cochrane Database of Systematic Reviews